Financial statements Salve Pharma
Balance sheet data of SALVE PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 584 137,75 | 2 164 043,15 | 1 930 061,77 | 2 548 465,49 | 2 418 538,22 | 2 616 873,88 |
| A. Fixed assets | 180 640,68 | 231 527,56 | 225 943,53 | 236 688,59 | 215 980,78 | 238 321,13 |
| B. Current assets | 1 403 497,07 | 1 932 515,59 | 1 704 118,24 | 2 311 776,90 | 2 202 557,44 | 2 378 552,75 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 1 584 137,75 | 2 164 043,15 | 1 930 061,77 | 2 548 465,49 | 2 418 538,22 | 2 616 873,88 |
| A. Equity | 638 926,78 | 712 161,18 | 703 981,76 | 575 329,53 | 576 802,57 | 457 967,42 |
| B. Liabilities and provisions for liabilities | 945 210,97 | 1 451 881,97 | 1 226 080,01 | 1 973 135,96 | 1 841 735,65 | 2 158 906,46 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | 818 759,77 | 1 346 349,64 | 1 101 632,05 | 1 821 479,78 | 1 674 984,43 | 1 933 360,73 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.